Canadian Patents Database / Patent 2362617 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2362617
(54) English Title: VASCULAR SYSTEM TREATING METHOD AND APPARATUS
(54) French Title: PROCEDE ET APPAREIL DE TRAITEMENT DU SYSTEME VASCULAIRE
(51) International Patent Classification (IPC):
  • A61N 5/00 (2006.01)
(72) Inventors :
  • WAKSMAN, RON (United States of America)
  • WELDON, THOMAS D. (United States of America)
  • HILLSTEAD, RICHARD A. (United States of America)
  • ROSEN, JONATHAN J. (United States of America)
  • LARSEN, CHARLES E. (United States of America)
  • CROCKER, IAN R. (United States of America)
  • MELOUL, RAPHAEL F. (United States of America)
(73) Owners :
  • BEST VASCULAR, INC. (United States of America)
(71) Applicants :
  • NOVOSTE CORPORATION (United States of America)
(74) Agent: FINLAYSON & SINGLEHURST
(45) Issued: 2006-05-16
(22) Filed Date: 1995-10-23
(41) Open to Public Inspection: 1996-05-09
Examination requested: 2001-11-26
(30) Availability of licence: N/A
(30) Language of filing: English

(30) Application Priority Data:
Application No. Country/Territory Date
08/330,327 United States of America 1994-10-27

English Abstract

This invention is an apparatus and method for delivering a treating element (22), such as a radiation source, through a catheter (60) to a desired site in a vascular system of a patient, such as a coronary artery, for inhibiting the formation of scar tissue such as may occur in restenosis following balloon angioplasty. The apparatus includes an elongate flexible catheter tube (20) having proximal and distal portions, with a lumen (202) extending therebetween, and a diameter sufficiently small for insertion into the patient's vascular system. One or more treating elements (22), such as a capsule or pellet containing radioactive material, is positionable within the lumen and movable between the proximal and distal end portions under the force of a liquid flowing through the lumen. The treating element that is usable in such a system comprises an elongated hollow cylinder closed on each end and a radiation-emitting substance encapsulated by the cylinder.


French Abstract

Cette invention concerne un appareil et une méthode d'administration d'un élément de traitement (22), par exemple une source de rayonnement, au moyen d'un cathéter (60), vers la région désirée dans le système vasculaire d'un patient, comme une artère coronaire, afin d'empêcher la formation de tissus cicatriciels observée dans les cas de resténose suivant l'angioplastie par ballonnet. L'appareil comprend un tube de cathéter flexible allongé (20) ayant des parties proximale et distale, avec une lumière (202) s'étendant entre elles, et un diamètre suffisamment petit pour être inséré dans le système vasculaire du patient. Un ou plusieurs éléments de traitement (22), comme une capsule ou un comprimé contenant une matière radioactive, est positionné dans la lumière et peut se déplacer entre les parties d'extrémité proximale et distale sous la force d'un liquide s'écoulant à travers la lumière. L'élément de traitement utilisable dans un tel système comprend un cylindre creux allongé et fermé, fixé à chaque extrémité, et une substance émettant des radiations, encapsulée dans le cylindre.


Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an exclusive property or privilege
is claimed
are defined as follows:

1. A treating element usable in a system for intraluminal treatment of a
selected site
in a body of a patient comprising an elongated hollow cylinder closed on each
end by at
least one end plug and a radiation-emitting substance encapsulated by the
cylinder, said
cylinder having at least one annular ridge spatially separate from said end
plug and
extending outwardly about the circumference of said cylinder.

2. A treating element usable in a system for intraluminal treatment of a
selected site
in a body of a patient comprising an elongated hollow cylinder open on each
end and
formed of a radiation-emitting substance, said cylinder having a metal coating
over said
radiative-emitting substance.

3. The treating element of claim 1 wherein the: cylinder is constructed of a
metal
selected from the group consisting of stainless steel, silver and titanium.

4. The treating element of claim 1 or 2 wherein the radiation-emitting
substance is
selected from the group consisting of alpha particle emitting substances, beta
particle
emitting substances and gamma particle emitting substances.

5. The treating element of claim 1 or 2 wherein the radiation-emitting
substance is
selected from the group consisting of Strontium90, Ruthenium106,
Phosphorous32, Iridium192
and Iodine125.

6. The treating element of claim 1 or 2 further comprising a lubricious
coating.

7. The treating element of claim 6 wherein the lubricious coating comprises
Teflon.

8. The treating element of claim 1 or 2 wherein the radiation-emitting
substance is
formed from a ceramic material that has absorbed a radioactive solution.

-36-



9. The treating element of claim 1 or 2 wherein the hollow cylinder has an
outside
diameter of between about .6 mm and .8 mm.

10. The treating element of claim 1 or 2 wherein the radioactivity of the
treating
element is between about .45 mCi to 25,000 mCi per centimeter length of the
treating
element.

11. The treating element of claim 2 wherein the cylinder is ring-shaped.

12. The treating element of claim 2 wherein the metal coating of the cylinder
over the
radiation-emitting substance is constructed of a metal selected from the group
consisting of
stainless steel, silver and titanium.

13. The treating element of claim 11 wherein the cylinder has at least one
annular
ridge extending outwardly about the circumference of the cylinder.

14. The treating element of claim 11 wherein said treating elements have
sufficient
activity to deliver a dose of between about 700 to 5,000 rads to the selected
site in
between 2 to 10 minutes.

15. The treating element of claim 11 usable in a system comprising at least
one lumen
for said treating elements to pass therethrough for intraluminal treatment of
a selected site
in a body of a patient, the lumen having an inner diameter of a given size and
wherein
the elongated hollow cylinder is more than half the size of the inner diameter
of said
lumen.

16. A plurality of treating elements usable in a system for intraluminal
treatment of a
selected site in a body of a patient, each treating element comprising an
elongated hollow
cylinder closed on each end by an end plug and a radiation-emitting substance
encapsulated by the cylinder, the treating elements being joined together by
spring wire
attached to the end plug of each cylinder to form a train.

-37-



17. The treating elements of claim 16 wherein the cylinder is constructed of a
metal
selected from the group consisting of stainless steel, silver and titanium.

18. The treating elements of claim 16 wherein the radiation-emitting substance
is
selected from the group consisting of alpha particle emitting substances, beta
particle
emitting substances and gamma particle emitting substances.

19. The treating elements of claim 16 wherein the radiation-emitting substance
is
selected from the group consisting of Strontium90, Ruthenium106,
Phosphorous32, Iridium192
and Iodine125.

20. The treating elements of claim 16 further comprising a lubricious coating.

21. The treating elements of claim 20 wherein the lubricious coating comprises
Teflon.

22. The treating elements of claim 16 wherein the radiation emitting substance
is
formed from a ceramic material that has absorbed a radioactive solution.

23. The treating elements of claim 16 wherein the hollow cylinder has an
outside
diameter of between about .6 mm and .8 mm.

24. The treating elements of claim 16 wherein the radioactivity of the
treating elements
is between about .45 mCi to 25,000 mCi per centimeter length of treating
elements.

-38-


Note: Descriptions are shown in the official language in which they were submitted.


CA 02362617 2001-11-26
WO 96/13303 PCT/US95I13728
---Vascular System Treating Method and Apparatus----
This application is a division of Canadian Patent
File No. 2,203,362 filed October 23, 1995.
FIELD OF THE INVENTION
The present invention relates generally to the delivery of
treating elements by a catheter to a selected site within the
vascular system of a patient. More particularly, the present
invention relates to method and apparatus for the delivery of a
treating element, such as a radiation source, through a catheter
to a desired site, such as a coronary artery, for inhibiting
wound healing response, such as restenosis following balloon
angioplasty.
BACKGROUND OF THE INVENTION
It is known that the human body's healing response to wounds
typically includes the formation of what is commonly called scar
tissue. This response also occurs within the vascular system of
a person following injury to a blood vessel. An injury that
provokes the formation of scar tissue may occur in various
locations within the vascular system, such as in the carotid
artery or in coronary bypasses, or in various ways, such as
trauma from surgical or diagnostic procedures.
One area of the vascular system of particular concern with
respect to such injuries is coronary arteries that are subjected
to procedures for removing or reducing blockages due to plaque
within the arteries. Partial and even complete blockage of
coronary arteries by the formation of an atherosclerotic plaque
is a well known and frequent medical problem. Such blockages may
t.


CA 02362617 2001-11-26
WO 96/13303 PCT/US95/13728
be treated using atherectomy devices, which mechanically remove
the plaque; hot or cold lasers, which vaporize the plaque;
stents, which hold the artery open; and other devices and
procedures which have the objective of allowing increased blood
flow through the artery. The most common such procedure is the
percutaneous transluminal coronary angioplasty (PTCA) procedures
-- more commonly referred to as balloon angioplasty. In this
procedure, ~a catheter having an inflatable balloon at its distal
end is introduced into the coronary artery, the uninflated
balloon is positioned at the stenotic site and the balloon is
inflated. Inflation of the balloon disrupts and flattens the
plaque against the arterial wall, and stretches the arterial
wall, resulting in enlargement of the intraluminal passageway and
increased blood flow. After such expansion, the balloon is
deflated and the balloon catheter removed.
PTCA is a widely used procedure and has an initial success
rate of between 90 and 95 percent. However, long term success of
PTCA (as well as the other artery-opening procedures referred to
above) is much more limited, due largely to restenosis, or re-
closing of the intraluminal passageway through the artery.
Restenosis, wherein the vessel passageway narrows to
approximately 50% or less of the enlarged size, is experienced in
approxir.~ately 30 to 50 percent of the patients within six months
after PTCA. Restenosis may occur for various reasons, but it is
now believed that restenosis is, in significant part, a natural
healing response to the vessel injury caused by inflation of the
angioplasty balloon.
Vessel injury may occur in several ways during PTCA,
including: denudation (stripping) of the endothelium (the layer
of flat cells that line the blood vessels); cracking, splitting
and/or disruption of the atherosclerotic plaque and intima
(innermost lining of the blood vessel); dehiscence (bursting) of
the intima and the plaque from the underlying media; stretching
and tearing of the redia and adventitia (outside covering of the
artery) which may result in aneurysmal expansion; and injury to
the vessel smooth muscle. Such injury to the vessel typically
initiates the body's own natural repair and healing process.
- 2 -


CA 02362617 2005-02-21
During this healing process, fibrin and platelets r~~.pidly accumulate in the
endothelium, and
vascular smooth muscle cells proliferate and migrate into the intima. The
formation of
scar tissue by smooth muscle proliferation, also laiown as intimal
hyperplasia, is believed
to be a major contributor to restenosis following galloon angioplasty of the
coronary
artery.
Prior attempts to inhibit restenosis of coronary arteries have included, among
other
things, the use of various light therapies, chemoth~~rapeutic agents, stems,
atherectomy
devices, hot and cold lasers, as well as exposure of the stenotic site to
radiation. These
therapies have had varying degrees of success, and certain disadvantages are
associated
with each of these therapies. Although radiation therapy has shown promise,
particularly
in inhibiting intimal hyperplasia, the devices available for delivery of
radiation sources to a
stenotic site have been limited and have tended to suffer from drawbacks which
limit their
usefulness. Typical of the devices using radiation to treat restenosis are
those shown or
described in U.S. Patents Nos. 5,059,166 to Fische:ll; 5,213,561 to Weinstein;
5,302,168 to
Hess; 5,199,939 to Dake; 5,084,002 to Liprie; and 3,324,847 to Zoumboulis.
SUMMARY OF THE INVENTION
The present invention is directed to apparatus and methods for delivering one
or
more treating elements, such as a radiation source, through a catheter to a
desired location
in the vascular system of a human patient and to r<;trieving the treating
elements) through
the catheter, if so desired. The present invention i;~ particularly
applicable, but not limited,
to the treatment of coronary arteries that have been or will be subjected to
PTCA or other
artery-opening procedures, in order to inhibit intirnal hyperplasia and reduce
the risk of
restenosis. The present invention is also useful in other areas of the
vascular system, such
as in the carotid artery or in coronary bypasses.
The invention to which the claims in this divisional application are
particularly
directed relates to a treating element usable in a sy;,tem for intraluminal
treatment of a
selected site in a body of a patient comprising an e'.ongated hollow cylinder
open on each
end and formed of a radiation-emitting substance, said cylinder having a metal
coating
over the radiation-emitting substance.
-3-


CA 02362617 2005-02-21
Another aspect of the invention provides a treating element usable in a
system for intraluminal treatment of a selected site in a body of a patient
comprising
an elongated hollow cylinder closed on each end by at least one end plug and a
radiation-emitting substance encapsulated by the cylinder, the cylinder having
at least
one annular ridge spatially separate from thc~ end plug and extending
outwardly
about the circumference of the cylinder.
Still further the invention provides a plurality of treating elements usable
in a
system for intraluminal treatment of a selected site in a body of a patient,
each
treating element comprising an elongated hollow cylinder closed on each end by
an
end plug and a radiation-emitting substance encapsulated by the cylinder, the
treating
elements being joined together by spring wire attached ~to the end plug of
each
cylinder to form a train.
More specifically, as described more fully herein, the apparatus comprises an
elongated flexible catheter tube having a proximal end portion adapted to
remain
outside the patient's body,-a distal end portion adapted to be positioned at a
selected
location within the vascular system of the patient and a lumen extending
therebetween, with the diameter of the catheter tube being sufficiently small
for
insertion into the patient's vascular system. 'The catheter tube is preferably
but not
necessarily adapted for positioning the distal end of the tube at the desired
site by
advancement over a guide wire. A port is provided at the proximal end portion
of
the tube, through which blood-compatible liquid may be introduced from a
source of
such liquid into the lumen. One or more treating elements, which may be in the
form of a solid capsule, pellet or the like, such as a capsule or pellet
containing
radioactive material, is positionable within thn lumen and is movable between
the
proximal and the distal end portions of the tube under the motive force
exerted by
the liquid flowing through the lumen.
Further the disclosed invention, a method is also provided for treating a
selected area in the vascular system of a patient wherein an elongated
flexible
catheter tube having a distal end portion adapted to be positioned at a
selected location within the vascular system of the patient, a proximal
_q._


i
CA 02362617 2001-11-26
,~ '~ 'WO 96/13303 PC'T/E)S9SII3718
end portion adapted to remain outside the patient's body, a lumen
extending therebetween, and a diameter sufficiently small for
insertion into the patient's vascular system is introduced into
the vascular system of a patient. The catheter is preferably but
not necessarily introduced over a guide wire until the distal end
portion of the tube is within the selected area of the vascular
system. A port communicating with the first lumen is adapted for
introduction of blood-compatible liquid into the lumen. One or
more treating elements, such as a capsule or pellet containing
radioactive material, is introduced into the lumen at the
proximal end portion of the tube and is moved from the tube's
proximal end portion through the lumen to the distal end portion
within the selected area by flowing the blood-compatible liquid
through the lumen to generate a motive force on the element so as
to move it from the proximal end to the desired location at the
distal end portion. There, the treating element is allowed to
remain a sufficient time for treatment of the selected area,
during which time the remaining portion of the catheter is free
of treating elements so as to not unnecessarily expose other
tissue to such treatment. After the treatment is completed, the
catheter tube is removed from the patient.
In another embodiment, the disclosed invention is embodied in
an angioplasty balloon catheter having proximal and distal end
portions, with a lumen extending therebetween. The lumen
communicates with an inflatable balloon located on the distal end
portion. In accordance with the present invention, one or more
treating elements, such as a radiation source, is either carried
fixedly at the balloon or moved through a lumen from the proximal
end portion to the distal end portion, for delivery of radiation
to the stenotic site as the angioplasty procedure is actually
carried out -- therefore allowing what may otherwise be a two-
step process to be carried out in a single step. From this
summary, it should be apparent that tha method of the present
invention may be carried out before, during or after an
angioplasty or other artery-opening procedure, whichever is
deemed most desirable by the treating physician.
-S-


CA 02362617 2001-11-26
R'O 96/13303 PCTIUS95/13728
DRAWINGS
Figure 1 is a diagrammatic representation of a catheter-
based treatment delivery system embodying the present invention.
Figure 2A is cross-sectional view of one embodiment of the
proximal end portion of the treatment delivery system of the
present invention.
Figure 2B is a cross-sectional view of another embodiment of
the treatment delivery system of the present invention.
Figure 2C is a cross-sectional view of still another
embodiment of the treatment delivery system of the present
invention.
Figure 3 is a cross-sectional view of one embodiment of the
treating elements of the present invention.
Figure 4 is a partial cross-sectional view of one embodiment
of the elongated catheter tube of the present invention, showing
the treating elements disposed in the distal end portion of the
tube.
Figure 5 is a partial cross-sectional view of a second
embodiment of the elongated catheter tube of the present
invention, showing the treating elements in the distal end
portion of the tube.
Figure 6A is a partial cross-sectional view of a third
embodiment of the elongated catheter tube of the present
invention, showing the treating elements in the distal end
portion of the tube.
Figure 6B is a partial cross-sectional view of the Figure 6A
embodiment of the elongated catheter tube of the present
invention, disposed within an outer guiding catheter which may be
used to position the catheter tube of the present invention
within the body of a patient.
Figure 7A is a partial cross-sectional view of a fourth
embodiment of the elongated catheter tube of the present
invention, showing the treating elements disposed in the distal
end portion of the tube.
Figure 7B is a partial cross-sectional view of the elongated
catheter tube of Figure 7A taken along line 7-7H.
-6-


CA 02362617 2001-11-26
R'O 96/13303 PC?1US95JI3728
Figure 8A is a partial cross-sectional view of a fifth
embodiment of the elongated catheter tube of the present
invention, showing the treating elements in the distal end
portion of the tube.
Figure 8B is a partial cross-sectional view of a modified
version of the embodiment of the elongated catheter tube of
Figure 8A, showing the treating elements in the distal end
portion of the tube.
Figure 9 is a partial cross-sectional view of a sixth
l0 embodiment of the elongated catheter tube of the present
invention showing toroidal or ring-shaped treating elements in
the distal end portion of the tube.
Figure l0A is a partial cross-sectional view of an
alternative embodiment of the present invention having an
inflatable balloon and treating elements fixedly positioned on
the distal end portion.
Figure lOB is an end view of the catheter of Figure 10A.
Figure 11 is a partial cross-sectional view of an
alternative embodiment of the present invention having an
inflatable balloon, with the treating elements disposed therein.
Figure 12 is a partial cross-sectional view of another
alternative embodiment of the present invention having an
inflatable balloon, with the treating elements movable along the
catheter.
Figure 13 is a partial cross-sectional view of a further
alternative embodiment of the present invention having an
inflatable balloon, with the treating elements movable along the
catheter.
Figure 14 is a partial cross-sectional view of another
embodiment of the treatment delivery system of the present
invention.
Figure 15A is a partial cross-sectional view of a,further
embodiment of the treatment delivery system of the present
invention.
Figure 15B is a elevational view of part of the proximal end
portion of the treating system shown in Figure 15A.
SUBSTfTUTE SHEET (RULE 26)


CA 02362617 2001-11-26
WO 96/13303 PCTIUS95/13728
Figure 15c is a cross-sectional view taken along lines 15c-
15c of Figure 15A.
Figure 16 is a partial cross-sectional view of various parts
of a further embodiment of the treatment delivery system of the
present invention.
Figure 17 is a partial cross-sectional view of another
alternative embodiment of the present invention having an
inflatable balloon, with the treating elements movable along the
catheter.
Figure 18 is a partial cross-sectional view of still another
alternative embodiment of the present invention having an
inflatable balloon, with the treating elements movable along the
catheter.
Figure 19 is a partial cross-sectional view of still another
alternative embodiment of the present invention having an
inflatable balloon, with the treating elements movable along the
catheter.
_a-
SUBSTITUTE SHEET (RULE 26)


CA 02362617 2001-11-26
WO 96/13303 PCT/US95113728
DETAILED DESCRIPTION
Figure 1 depicts one embodiment of the present invention in
general diagrammatic form for ease of initial understanding.
Shown in Figure 1 is an elongated catheter 2 having a proximal
end portion 4, a distal end portion 6, and at least one lumen 8
extending therebetween. The catheter is sized for insertion of
the distal end portion through the vascular system of a patient
to a selected area to be treated, such as the site of a balloon
angioplasty procedure or other opening procedure, such as an
atherectomy, in a coronary artery. This may be carried out, for
example, by inserting the catheter percutaneously into a femoral
artery and advancing the catheter over a typical guide wire 10
upwardly through the descending aorta, over the aortic arch,
downwardly through the ascending aorta and into the particular
coronary artery that has been selected for treatment, such as a
coronary artery that has been subjected to PTCA or other artery-
opening procedure. Guide wires and procedures used in advancing
such a catheter to the point of the angioplasty procedure are
well known and will not be discussed in detail.
At the proximal end of the catheter, which is located
outside the patient in a percutaneous procedure such as described
above, a transporting and/or loading device 12 is provided for
loading a treating element, such as a pellet or capsule
comprising or containing radioactive material, into the lumen 8
of the catheter 2. Additional treating elements may also be
loaded such that the total length of the combined treating
elements corresponds to at least the length of the stenotic area
of the vasculature to be treated. The total length of the
combined treating elements also could be longer than the stenotic
area in order to assure that the end edges of the stenotic area
are also treated. This loading procedure may also be performed
manually, but a mechanical loader as described in more detail
later is preferred to provide better user protection against
radiation.
After the treating element is loaded into the lumen 8,
pressurized blood-co.::patible liquid, such as sterile saline
_g_


CA 02362617 2001-11-26
r~ WO 96113303 PrTNS95113728
solution or sterile water, is introduced via liquid source 14
through a port 16 in the proximal end of the lumen behind the
treating element. Flow of liquid through the lumen pushes the
treating element along the lumen to the distal end portion, which
is located at the site to be treated. The liquid which provides
the motive force for moving the treating element may be allowed
to exit from the distal end of the catheter or may be returned in
a parallel lumen provided in the catheter or may be returned via
suction through the same lumen in which the treating element
travels.
After the treating element is located at the desired site,
the treating element is allowed to remain for a time sufficient
to treat the tissue. For radiation treatment of a stenotic site,
the treating element preferably are beta-emitting radiation
sources, and the residence time period will be relatively short,
on the order of minutes as discussed in more detail below.
After the treatment is complete, the catheter may be removed
with the treating element remaining at the distal end or,
alternatively, liquid may be forced through the lumen in a
reverse direction to return the treating element to the proximal
end and into the loading device, if desired, before removal of
the catheter. The reverse flow of fluid may be achieved by
forcing liquid under positive pressure through the lumen in a
reverse direction or by applying a suction, such as by
withdrawing the piston of a syringe attached at the proximal end
of the lumen, to the lumen.
The transporting/loading device 12 need not be connected
directly to the proximal end of the catheter 2 if such direct
connection would result in possible kinking of the catheter or
would restrict maneuverability. In that case, an additional
length of tubing (which may have the same number of lumens as the
catheter) could be provided between the transporting/loading
device 12 and the proximal end portion 4 of the catheter. In
such event, the additional length of tubing (as well as the
proximal end portion of the catheter located outside the patient)
may be shielded to protect the user and/or the patient from
unnecessary radiaticn exposure.
- 10 -


CA 02362617 2001-11-26
WO 96/13303 PCTJUS95/13728
Figure 2A shows one actual embodiment of the proximal end of
the catheter system depicted in Figure 1. Although not limited
to use with radioactive treating elements, the device shown in
Figure 2A is particularly adapted for that application.
Specifically, Figure 2A depicts a three-lumen catheter
system 18 with a loading device 20 containing treating elements
22 and connected to the proximal end of a three lumen catheter
tube 24. The loading device comprises a rigid body 26 preferably
of a suitable rigid polymer, having a proximal end 28, a distal
end 30 and a first, a second and a third bore, 32, 34 and 36
respectively, extending therebetween. A fitting 38 located at
the distal end of the body connects the first, second and third
bores, respectively, with one of the three lumens 33, 35 and 37
of the catheter tube 24.
At the proximal end of the housing member, ports, such as
luer connector ports, are provided for communication with bores
32, 34 and 36. A first port 40 is aligned with the first bore 32
of the body and is adapted for the entry or exit of a liquid,
such as sterile saline. A second port 42 is in communication
with the second bore 34 of the housing member and is likewise
adapted to permit the entry or exit of liquid into the body. The
third port 44 opens into the third bore of the body and is
adapted to receive a guide wire 46 to aid in positioning the
distal end of the catheter tube within a patient. A valve (not
shown), such as a Touhy-Borst valve, may be attached to the third
port to prevent leakage of fluid around the guide wire during or
after insertion of the device into the patient.
For loading and/or unloading of the treating elements 22, a
retaining device such as a magazine, carrier or carriage 48 is
slidably positioned within a slot 50 defined in the body 26
intermediate the proximal and distal ends. The carriage is
preferably constructed of the same material as the rigid body 26
and has a first through bore 52 and a second through bore 54.
The first and second through bores of the carriage may be
selectively aligned with the first bore 32 of the body, depending
upon the lateral position of the carriage relative to the body.
A carriage with only a single through bore may also be used.
_ 11 -


CA 02362617 2001-11-26
WO 96/13303 PCT/US95113728
Hy pre-loading the treating elements into the carriage, they
may be conveniently handled, shipped and stored separate from the
rest of the loading device. When the user is ready for the
procedure, the carriage may be simply inserted into the body,
thereby minimizing handling of the treating elements by and
exposure to the user. The carriage is preferably made of a
material and has sufficient thickness to protect the user against
unnecessary exposure to radiation when the treating elements are
radioactive.
As shown in Figure 2A, carriage 48 is fully inserted into
the body 26, with the first bore 52 of the carriage aligned with
the first bore 32 of the body. In this position, second bore 54
of the carriage contains the treating elements 22 and is
positioned within the body, thereby providing protection of the
user from radiation emitted by the treating elements. In this
first position, fluid, such as sterile saline, may be introduced
through the first port to prime the body and catheter and remove
any air contained therein, if so desired.
By sliding the carriage 48 outwardly from the body 26, the
carriage is moved into a second position wherein second bore 54
of the carriage is coaxially aligned with first bore 32 of the
body, and the treating elements 22 are ready for introduction
into the catheter 24. In this second position, pressurized
liquid, such as sterile saline, may be introduced via puap 14
through first port 40 to supply the motive force against the
treating elements 22, ejecting them from second through bore of
the carriage, distally through the first bore 32 of the body, and
into a lumen of the catheter.
The specific design of the pump 14 may be chosen from
various alternatives. For example, the pump 14 may be a simple
saline-filled piston syringe attached via leer lock connector to
port 40 of body 26. Manual depression of the syringe plunger
would provide sufficient force to eject the treating elements and
move them to the desired position in the catheter (and withdrawal
of the plunger may assist in returning the treating elements to
the proximal end portion after the treatment is complete).
Alternatively, the motive force a~ay be provided by a column of
_ 12 -


CA 02362617 2001-11-26
1 WO 96113303 PC?/US95113718
liquid from a suspended container of sterile saline or water,
controlled by a simple roller clamp or stopcock.
Alternative configurations for the carriage (not shown) also
may be used without departing from the scope of the present
invention. For example, the carriage may be cylindrical and/or
rotatably mountable within the body. Through bores or chambers
within the carriage may be selectively brought into alignment
with the bores of the body by rotating the carriage. The
treating elements may be pre-loaded in the cylinder to minimize
user contact and to protect the user from radiation when a
radioactive treating element is employed. By providing the
treating elements 22 pre-loaded into a loading device 20 or pre-
loaded into a carriage 48 that may be inserted into a loading
device, user contact with the treating elements is minimized, and
for radioactive treating elements, the user may be shielded from
radiation.
Figure 2B shows a further alternative embodiment of a
catheter system of the present invention. Catheter system 56
includes a combination loading device and pump 58 and a multi-
lumen catheter 60. The combination pump and loading device
comprises a body portion 62 having a distal end portion 64
attached to the elongated catheter tube and a proximal end
portion 66 mounting connectors for fluid communication with
passageways defined in the body.
The body portion 62 has a central bore or passageway 68 in
which treating elements 22 are located prior to the treatment and
after the treatment is completed. The central bore 68
communicates directly with one of the lumens of multi-lumen
catheter 60. Discharge of the treating elements from the bore 68
is controlled by gate 70, which a~ay be moved between positions
blocking flow or allowing flow through central bore.
Alternatively, the gate may contain openings of sufficiently
small size to permit fluid to pass therethrough, while preventing
passage of the treating elements while the gate blocks the
central bore. This aids in priming the system with the treating
elements in position in bore 68, if so desired.
_ t3 -


CA 02362617 2001-11-26
WO 96/13303 PCT/US95113718
For providing the pressurized flow of liquid to transport
treating elements to and from the distal end of catheter 60, a
pair of piston-cylinder arrangements are provided on opposite
sides of the body portion 62. Piston-cylinder arrangement 72
provides the liquid flow for dispatching the treating elements
to the distal end of the catheter and piston-cylinder arrangement
74 provides the reverse liquid flow for retrieving the treating
elements therefrom.
Interior passageway 76 in the body 62 communicates between
l0 liquid inlet port 78, central bore 68 and the cylinder of
dispatch piston-cylinder arrangement 72, which provides the fluid
flow for moving the treating elements into and along a principal
lumen of the catheter 60. One-way, spring loaded ball valve 80
within passageway permits liquid to enter through the inlet port
but blocks liquid from exiting from the port. Vent 79 allows
displacement air to exit from the passageway 76 when liquid is
added, for priming purposes and the like, and a pressure relief
valve 81 may be provided to prevent overpressurization of the
catheter.
Interior passageway 82 in the body 62 communicates between
the cylinder of the retrieval piston-cylinder arrangement 74 and
a return lumen of the catheter 60. At the distal end portion of
the catheter, the return lumen communicates with the principal
lumen to provide a closed circulation path for the liquid that
dispatches and retrieves the treating elements.
In addition, the body 62 has a third interior passageway 84
that com.~nunicates between guide wire inlet 86 and a guide wire
lumen of the catheter 60. By itself, the catheter 30 may not
have sufficient strength or torsional rigidity for insertion
3o along a lengthy serpentine vascular path -- in typical
angioplasty procedures, the distance between the percutaneous
entry point and the coronary artery may be approximately 3-4 feet
(90-120 cm). To assist in positioning the distal end of the
catheter at the desired location, the catheter may be advanced
over a guide wire that is pre-inserted to the desired location in
a manner well known to those skilled in performing angioplasty
and similar procedures. The guide wire inlet preferably includes
- 14 -


CA 02362617 2001-11-26
WO 96/13303 PGT/US95I13728
a Touhy-Borst valve or similar known device to close the guide
wire inlet around the guide Wire to restrict leakage of blood or
other fluid from the guide wire lumen.
In use, the interior passageways, piston-cylinder
arrangements, and catheter principal and return lumen are filled
with sterile water or saline through the liquid inlet port 78 and
one-way valve 80. In the initial position, the dispatch and
retrieval piston-cylinders are oppositely positioned, with the
piston of the dispatch piston-cylinder 72 in a withdrawn
l0 position, as shown in Figure 2B, and the piston of the retrieval
piston-cylinder 74 in an advanced position, also as shown in
Figure 2B. Before the treating elements can be moved to the
desired position, gate 70 controlling the central bore must be
opened.
By advancing the dispatch piston, the liquid in the dispatch
cylinder is forced through the interior flow path 76 and into the
central bore 68 containing the treating elements 22. The
pressurized liquid flow ejects the treating elements from the
central bore and forces the treating elements along the principal
lumen of the catheter to the distal end portion located at the
site to be treated. As liquid moves along the principal lumen in
a distal direction, it displaces an equal amount of liquid that
returns along the return lumen and enters the cylinder of the
retrieval piston-cylinder arrangement 74, pushing the retrieval
piston outwardly.
Retrieval of the treating elements may be accomplished by
reversing the steps described above. The retrieval piston is
advanced, forcing liquid in a reverse or distal direction along
the return lumen and returning the fluid to the body along the
principal lumen. The liquid flow moves the treating elements in
a proximal or return direction along the principal lumen,
returning them to the central bore of the body 62. The returning
liquid enters the cylinder of the dispatch piston-cylinder
arrangement 72.
With the catheter system as shown in Figure 2B, a
completely closed system is provided, and no liquid that contacts
the treating elements is allowed to enter the patient's body.
- 15 -


CA 02362617 2001-11-26
R'O 96/13303 PCT/US95113728
This may be particularly important when the treating agent is
radioactive. The closed system arrangement also allows the
treating elements, whether a single element or a train of
treating elements, to be shifted back and forth slightly while in
the distal portion of the catheter by alternately slightly
depressing the dispatch and retrieval pistons. This technique
may be used to provide a more uniform exposure of the selected
vessel area, particularly where there is dead space between or at
the ends of the treating elements.
l0 A variation on the catheter system of Figure 2B is depicted
in Figure 2C. The catheter system 88 shown there similarly
includes a combination pump and loading device 90 and a multi-
lumen catheter 92. The combination pump and loading device 90
also has a body portion 94 with a distal end portion 96 attached
to the catheter 92, and a proximal end portion 98. In this
embodiment, however, liquid inlet port 100, guide wire inlet 102
and dispatch and retrieval bellows 104 and 106, respectively, are
located on one side of the body 94. This arrangement permits a
large cylindrical chamber 108 to be provided, extending inwardly
from the proximal end of the body, for receiving a carrier or
insert 110 which is pre-loaded with treating elements 22.
Alternatively, the body 94 and insert 110 could be of one piece
or integral construction.
Insert 110 has a central bore 112 in which the treating
elements are located, a gate 114 controlling passage of the
treating elements from the central bore, and a laterally
extending branch 116 of the central bore. When inserted into the
chamber 108 of the body 94, central bore 112 of the insert 110 is
aligned with central passageway 118 of the body 94, which
communicates directly with a principal lumen of the catheter 92,
and branch 116 communicates with internal passageway 120 of the
body, which connects to the liquid inlet port 100 and the
dispatch bellows 104.
Alternatively, the insert 110 could have a plurality of
bores and be rotatably mounted in the body for selective
alignment of the bores with inlet port 100 and central passageway
118. In this arrangement, one bore could be empty for fast
- 16 -


CA 02362617 2001-11-26
WO 96/13303 PCT/US951I37Z8
priming of the system and another bore could contain the treating
elements.
As with the embodiment in Figure 2B, an internal liquid
flow passageway 122 is provided in the body 94, communicating
between the retrieval bellows and a return lumen of the catheter
92, and a guide wire passageway 124 is provided between a guide
wire lumen of the catheter and guide wire inlet 102. Also
similarly, a vent 126 is provided in communication with the
passageway that connects with the liquid inlet port 100.
l0 In operation, the catheter system of Figure 2C is
essentially identical to that discussed regarding Figure 2B. The
embodiment of Figure 2C allows the treating elements to be
conveniently stored separately from the remainder of the catheter
system, for example in special radiation-proof containers.
It should be clear that in each of the embodiments discussed
above, the body, carrier (insert or carriage) and catheter may be
provided in various combinations of assemblage, as a matter of
choice. For example, the body and carrier could be preassembled
or even of one piece construction. Similarly, the body could be
preassembled with the catheter tube, with the carrier separate
for convenient storage and transportation of the treating
elements. Alternatively all three elements could be separate and
assembled in the desired configuration on site -- this would
permit the physician to select the appropriate combination
depending on the desired procedure.
For radiation exposure of the desired site, the treating
elements 22 contain radioactive material, preferably beta-
emitting. In the preferred embodiment shown in Figure 3, the
treating elements are elongated hollow cylinders 128 which are
preferably constructed of stainless steel, silver, titanium or
other suitable material, and are ideally in the range of 2.5 to
5.5 mm in length. The cylindrical treating elements have rounded
first and second ends with a chamber 130 extending therebetween.
The inner diameter of chamber 130 is preferably in the range of
0.4 to 0.6 mm. A first end plug 132 closes the first end of the
cylinder, while a second end plug 134 closes the second end. The
_ 17 _


CA 02362617 2001-11-26
WO 96113303 PCT/US951I3728
end plugs are preferably less than about 1 mm in width and are
affixed to cylinder 128, for example, by welding.
The outer diameter of the treating elements is preferably
between approximately 0.6 and o.8 mm, being sized, of course, to
slidably fit into the respective receiving bores of the
carriages, bodies and catheter lumen described above. To permit
maximum mobility through the loading devices and catheters
described above, the inner diameter of each of the bores or
lumens the treating elements pass through should preferably be
less than twice the outer diameter of the cylindrical treating
elements and the outer surface of the treating elements may be
coated with Teflon material or similar low-friction material to
reduce friction between the treating element and the wall of the
lumen in which it moves. This allows the treating elements to
move quickly through the lumen, minimizes unnecessary exposure of
other tissue to the treating elements and in particular minimizes
radiation exposure to other tissue. Additionally, to increase
the surface area of the treating elements subject to the motive
force provided by fluid being passed through the system, the
treating elements may also be provided with one or more annular
ridges which extend outwardly about the circumference of the
treating elements.
To treat a length of vascular tissue, a plurality of
treating elements, joined together to form a train of treating
elements, as illustrated in the attached figures, may be used.
To keep the treating elements uniformly spaced from each other,
and, more importantly, to prevent the treating elements from
becoming too spaced apart while moving through the catheter, the
individual treating elements may be connected by several lengths
of hard tempered spring wire 136, as is shown in Figure 3.
Each treating element 22, as constructed above, encapsulates
a therapeutic agent, such as a radiation emitting substance 138.
Radiation emitting substance 138 is contained within interior
chamber 130 of the treating element and may be composed of any
alpha, beta or gamma particle emitting substance. Preferably,
however, the radioactive source is a pure beta-particle emitter,
_ 18


CA 02362617 2001-11-26
R'O 96113303 PCT/US95l13728
,r beta and gamma emitter. Examples of such substances include
Strontium9°, Ruthenium'°6, Phosphorus3Z, Iridium~92, and/or
Iodine~25.
The amount and strength of the radioactive material
contained in the combined number of treating elements 22 should
be sufficient to deliver a desired dosage of from 100 to about
10,000 rads, preferably about 700 to 5,000 rads, in about 2-10
minutes. Radioactivity is generally measured in units of "Curie"
(Ci), and the radioactivity of the material for the present
invention is selected to provide the above dosage. For the
preferred dosage, the radioactive material may have a
radioactivity of approximately 0.45 and 25,000 mCi per centimeter
of vessel to be treated, depending on the radiation source used.
As described briefly earlier, when a train of treating elements
is used which have dead space (non-radioactive) between adjacent
elements, the train may be oscillated by moving the catheter
slightly back and forth or by briefly repeatedly reversing the
flow of liquid, resulting in a shifting back and forth of the
treating elements to provide a more uniform radiation exposure of
the selected area of the vessel.
The selected radioactive material may be contained within
glass, foil, or ceramics, or, alternatively, within a powder or
liquid medium, such as microparticles in liquid suspension. When
solid materials are used, the preferred outer diameter of the
material is approximately 0.5 mm, allowing it to be inserted into
the central chamber 130 of the treating element cylinder 128.
Such radioactive materials may be formed into pellets, spheres,
and/or rods in order to be placed into the chamber of the
treating element.
Various alternative treating elements may also be used to
contain the radioactive material without departing from the
present invention. For example, the treating elements nay be
toroidal, spherical, or in the form of elongated rings, and in
such configurations, the radioactive material may be actually
impregnated in a metal and formed into the desired shape.
Alternatively, a radioactive powder may be fired to fuse the
material so that it may be formed into the desired shape, which
may then be encapsulated in metal, such as titanium, stainless
_ 19 _


r
CA 02362617 2001-11-26
WO 96/13303 PC?/US95/13718
steel or silver, or in plastic, as by dipping in molten or
uncured plastic. In still another embodiment, the treating
elements may be formed from a ceramic material which has been
dipped in a radioactive solution. In a still further
alternative, the treating elements 22 may be constructed in the
form of two piece hollow cylindrical capsules having a larger-
diameter half with a central cavity and a smaller-diameter half
also having a central cavity, the smaller half slidably received
within the larger half and bonded or welded to form the capsule
structure.
Turning now to a more detailed description of the catheters
of the present invention, as stated previously, catheters of the
present invention may be pre-attached to the loading device or,
as discussed with regard to Figure 2, a fitting such as 38 may be
provided for attaching an elongated catheter tube to the loading
device. Although catheters of the present invention may vary in
the number of lumens or the specific construction of such lumens,
those catheters have in common, a proximal end attachable to a
body member such as body 26, a distal end opposite the body which
is adapted to be positioned at a selected site in the body, and
an elongated tubular portion therebetween. For those catheters
that are not pre-attached to the loading device, the proximal end
may be provided with a keyed fitting to allow attachment of only
certain catheters to the fitting on the loading device. Such
fittings may include those generally known in the art which will
not be discussed herein, but also may include specially designed
fittings which would be peculiar to this device. A specially
keyed fitting would prevent the inadvertent attachment of the
fitting or body to other catheters on the market which are not
specifically designed to receive the treating elements and/or to
prevent the treating elements from being released into the body.
As used herein, the terms "elongated tube," "elongated
catheter tube" and similar phrases are intended to include a
catheter possessing one or more lumens produced from a single
extrusion and catheters of multiple lumens wherein the catheter
is made up of several separate tubes bundled together.
- 20 -


CA 02362617 2001-11-26
WO 96J13303 PCT/US95/13?28
Figure 4 depicts the distal end portion of one catheter of
the present invention, generally at 140, with the treating
elements located in the distal end portion. In this embodiment,
the catheter comprises a single tubular member 142 having a
proximal end portion (not shown), a distal end portion and a
lumen 144 extending therebetween. The tubular member is
preferably extruded from Nylon 11 material, although other
suitable plastic materials may be used. The outer diameter of
the tubular member is sized according to the intended application
-- for example 5 French or smaller for use in treating the
stenotic site of a coronary artery. The inner diameter of the
lumen is correspondingly sized to receive the treating elements
22.
To prevent treating elements 22 from exiting the distal end
of the tubular member, a retention projection may be provided in
the lumen to block passage of the treating elements, such as an
end barrier 146. Barrier 146 is a separate molded tip adhered or
bonded to the distal end portion of tubular member 142. Barrier
146 preferably has a smooth rounded external surface to minimize
possible abrasion to a vessel or other tissue and a central
opening 148 to allow liquid flow therethrough.
To aid in placement of the catheter at the desired location,
a marker band 150 is attached to the outer surface of tubular
member 142 at the distal end portion. To provide a continuous
smooth outer surface, a slight undercut may be provided in the
surface of the catheter tube, in which the marker band resides.
Although shown on the exterior surface of the catheter, the
marker band may also be provided internally as well. Preferably
the barrier 146 and marker band 150 are constructed from barium,
a platinum-iridium compound, or like substance, which is visible
by fluoroscope during placement of the catheter.
In use, still referring to Figure 4, the distal end portion
of the tubular portion is introduced into the body of a patient
into a selected site, such as the coronary artery 152 following
balloon angioplasty. In such instances, a guide wire will
typically be pre-positioned in the patient, although a guiding
catheter could also be used. The distal end of the catheter is
_ 21 _


CA 02362617 2001-11-26
WO 96113303 PCT/US95/13718
then advanced over the guide wire, through lumen 144. The
positioning of the device is made more precise due to the ability
to fluoroscopically observe the barrier 146 and marker band 150
at the distal end portion of the catheter tube.
After the distal end portion of the catheter is positioned
such that the previously stenosed area, generally at 154, of the
coronary artery is located between the barrier 146 and marker
band 150, the guide wire can be removed, and the proximal end of
the catheter can be connected to a treating element loading
device and/or pump, as described earlier with reference to the
Figure 2-2B embodiments.
So connected, the treating elements 22 are in direct
communication with lumen 144 of the catheter and a flow path is
formed therebetween. Pressurized liquid, such as from a fluid
pump, syringe or other piston-cylinder arrangement, plunger, or
elevated saline solution container, is then directed against the
treating elements, causing them to advance along the catheter
lumen until stopped by the end barrier 146.
Referring to the Figure 2A embodiment of a loading device as
an example, to move the treating elements 22 from the body 26 to
the selected site in the patient, the carriage 48 is moved from
the first position to the second position. This releases the
treating elements into the flow path where they are carried
rapidly by the motive force of the fluid therein into and through
the lumen of the catheter to the distal end portion, which is
located at the stenotic site. The rapid transportation of the
treating elements reduces the amount of radiation which is
transmitted to tissues in the body through which the elongated
catheter tube extends. In this embodiment, the liquid
transporting the treating elements exits through the central
opening 148 in the end barrier 146.
As noted above, upon reaching the distal end portion of the
elongated tube, the treating elements are prohibited from being
ejected into the patient by the barrier 146. Once more, the
barrier and marker band may be used to fluoroscopically visualize
the released radioactive elements, and account for their
location. The barrier and marker band may be specifically spaced
- 22 -


1
CA 02362617 2001-11-26
WO 96/13303 PCT/US95I13728
to cover the distance of the lumen occupied by the total length
of the radioactive treating elements, and the location of the
elements may be confirmed by viewing a solid image between the
barrier and marker band on the fluoroscope.
To maintain the treating elements within the distal end
portion of the elongated tube, a constant fluid pressure through
the lumen and against the treating elements may be required to
counteract the effects of external blood pressure and/or
gravitational forces exerted upon the treating elements,
depending on the angle at which the distal end portion of the
elongated tuba is placed and on the specific location in the
patient.
Preferably, in order to sufficiently irradiate the stenotic
site of a coronary artery that has been subjected to PTCA to
inhibit intimal hyperplasia, the treating elements should remain
at the selected site for a sufficient time to deliver a
therapeutically effective amount of radiation, which is
preferably between about 100 and 10,000 tads, preferably about
700 to 5,000. The length of time required to deliver this dosage
of radiation depends primarily on the strength of the radioactive
source used in the treating elements and the number of treating
elements employed. The radioactivity needed will depend on the
strength of the source used and the emission, and may be in the
range of 0.45 to 25,000 mCi depending on the source. After
sufficient time, such as 2 to 10 minutes, has been allowed for
treatment, the treating elements may be removed by withdrawing
the catheter from the patient or by applying suction (such as by
a syringe) to the proximal end of the lumen in which the treating
element travels.
Another embodiment of an elongated catheter tube 156 of the
present invention is shown in Figure 5. The proximal end of the
catheter tube may be pre-attached to a loading device/punp or
employ a fitting fox keyed attachment to such a device, as
described in detail earlier. Accordingly, only the distal end
portion of the catheter is depicted in Figure 5.
As shown in Figure 5, the elongated tube 156 comprises co-
axial inner and outer tubes 158 and 160 respectively. Inner tube
- 23 -


CA 02362617 2001-11-26
WO 96/13303 PC"T/US95113728
_58 defines an inner bore or lumen 162, through which the
treating elements 22 are advanced. Inner and outer tubes are
spaced apart to define to define a return lumen 164 therebetween
for return of the liquid used to advance the treating elements.
The distal end of the outer tube 160 tapers to a narrow,
flexible and atraumatic tip 166 bonded to the outer tube. A
radiopaque barrier 168 located slightly beyond the end of the
inner tube 158 closes the outer tube 160 and blocks further
proximal movement of the treating elements 22. Similarly to
marker band 150 of the previous embodiment, a marker band 170 may
be provided in an undercut area on the surface of outer tube 160
at a location spaced proximally from the barrier 168 to enhance
placement of the distal end portion and the treating elements at
the desired location.
When used to treat the site of a coronary artery where a
balloon angioplasty procedure has been carried out, this catheter
156 is positioned in the previously stenosed site by a guide tube
or similar device. Positioning of the distal end portion of the
catheter may be viewed fluoroscopically due to the radiopaque
barrier 168 and marker band 170.
If not pre-attached to a loading device/pump, the proximal
end of the catheter is attached to such a device as described
earlier. Without unnecessarily repeating earlier description,
the treating elements 22 are advanced along the inner lumen 162
of the catheter under the force of liquid flowing therethrough.
With this embodiment, instead of exiting from the distal end of
the catheter, the liquid exits from the distal end of the inner
lumen (or through a side aperture 172 in the wall of the inner
tube), and returns through the return lumen 164 provided between
the inner tube and the outer tube. The return liquid may be
allowed to exit through the loading device/pump or may be
collected therein, as described earlier, for alternative,
disposal.
Unlike the first embodiment, this embodiment is a completely
closed system, in that the fluid is not released into the patient
and the treating elements 22 do not contact the blood. While
this eliminates the effects of blood pressure in moving the
- 24 -


CA 02362617 2001-11-26
WO 96/13303 PCTIUS95113728
treating elements, a small but constant fluid flow may be
required to maintain the treating elements in the distal end
portion of the elongated catheter tube due to the gravitational
effects in the event the treatment site is at a higher elevation
than the proximal end of the catheter. Hy oscillating the liquid
flow between the dispatch and retrieval pistons, the train of
treating elements 22 may be shifted slightly back and forth to
make the exposure along the desired area more uniform.
The radioactive treating elements remain in the distal end
portion of the elongated tube for a sufficient period of time to
deliver a therapeutically affective amount of radiation. As was
previously discussed, this is preferably about 100-10,000 tads,
in the case of inhibiting the development of intimal hyperplasia.
After a sufficient amount of radiation is delivered, the
treating elements 22 may be retrieved from the distal end portion
of the elongated catheter tube and returned to the loading device
by introducing pressurized fluid into the return lumen. This
reverses the flow of liquid and creates an oppositely directed
motive force on the treating elements forcing them proximally
through the inner lumen 162 for return to the loading device. The
elongated catheter tube may then be removed from the patient and
the procedure concluded. Alternatively, the treating elements
may be removed by withdrawing the catheter from the patient.
In a third alternative embodiment of the present invention
shown in Figures 6A and 6B, the catheter is constructed and
operates similarly to that described for the Figure 5 embodiment.
Elongated catheter tube 174 comprises co-axial inner and outer
tubes 176 and 178 respectively. Inner tube 176 defines an inner
bore or lumen 180, through which the treating elements 22 are
advanced. Inner and outer tubes are spaced apart to define a
return lumen 182 therebetween for return of the liquid used to.
advance the treating elements.
The distal end of the outer tube 178 is not tapered, but is
closed by radiopaque solid tip 184, which also serves as a
barrier to the treating elements as they move along the inner
lumen 180. Also similarly, a marker band 186 is provided on the
surface of outer tube 178 at a location spaced proximally from
- 25 -


CA 02362617 2001-11-26
. WO 96113303 PCT/US95/13728
.he tip 174 to enhance placement of the distal end portion and
the treating elements at the desired location.
The initial placement of the distal end portion of
elongated catheter tube 174 is facilitated by the use of a third
or guide tube 188, as is shown in FIG 6B. As shown therein, the
separate third tube 188 has a proximal end portion (not shown), a
tapered distal end portion and a lumen 190 extending
therebetween.
In use, the guide tube has sufficient strength or rigidity
l0 for placement or is placed into the body of a patient over a pre-
positioned guide wire, so that the distal end portion of the
third tubular member is located at a specific selected site
within the body at which treatment is desired. Once the guide
tube is positioned at the selected site, and the guide Wire at
least partially pulled back, the elongated catheter tube 174
shown in Figure 6A may be inserted into lumen 190 of the guide
tube.
As in the Figure 5 embodiment, the embodiment shown in
Figures 6A and 6B allows treating elements 22 to be hydraulically
moved between the proximal and distal end portions of the
elongated tube, with the direction of the hydraulic flout being
determined by the pressure gradient existing between the delivery
and retrieval lumens. Thus, after maintaining the treating
elements at the distal end portion of the elongated catheter tube
for a desired period of time, the treating elements may be
retrieved by reversing the flow of fluid through the elongated
tube. Following this the catheter and third or guide tube may be
removed from the patient and the procedure concluded.
Another embodiment of the catheter of the present invention,
particularly intended for placement at a desired location by
advancement over a guide wire, is shown in Figures 7A and 7B.
The elongated catheter tube 192 comprises a pair of inner tubes
194 and 196 that extend in a parallel side-by-side arrangement
within an outer tube 198. Inner tube 194, which is of smaller
diameter than tube 196, defines an inner lumen 200 for receiving
a guide wire used for placement of the catheter at the desired
location within the patient. Inner tube 196, which is of larger
- 26 -


CA 02362617 2001-11-26
. WO 96113303 PCT/US95113728
diameter, provides inner lumen 202 along which the treating
elements 22 travel. Return lumen 204 is provided by the space
between the inner surface of the outer tube 198 and the outer
surfaces of the inner tubes 194 and 196 for return flow of liquid
used to transport the treating elements.
As seen in Figure 7A, the outer tube 198 has an open tapered
distal end. An interluminal wall 206 is provided within the
outer tube at the beginning of the taper and at the distal end of
the inner tubes 194 and 196. The wall 206 includes an aperture
in sealed communication with lumen 200 of inner tube 194, through
which a guide wire may pass. The wall 206 is preferably slightly
spaced from the distal end of the other inner tube 196, through
which the treating elements pass, to allow liquid to exit from
the end of tube 196 for return through the return lumen 206. The
wall also provides a barrier to prevent the treating elements
from exiting the end of tube 196.
As in the earlier embodiments, the elongated catheter tube
192 has first and second radiopaque marker bands, 208 and 210 on
the outer tube to aid in placing the distal end portion at the
desired location in the patient. As noted earlier, although
generally depicted on the outer tube in many of the embodiments,
the markers may be provided inside the catheter at any convenient
location, such as on an inner tube or surface, without departing
from the present invention.
In use for treating a stenotic site in a coronary artery
with radiation, the proximal end of the elongated catheter 192
tube may be pre-connected to a loading device/pump or separately
connected to such a device by a keyed fitting or similar
arrangement, as discussed earlier. The distal end portion of the
elongated catheter tube is then positioned at the selected site
within the body of the patient by advancing the catheter over a
pre-positioned guide wire. In this embodiment, the guide wire
may be allowed to regain in position. This has the significant
advantage that it is unnecessary to insert the guide wire a
second time if a further catheter or device needs to be inserted
after the treatment is completed.
- 27 -


CA 02362617 2001-11-26
WO 96113303 PC?/US95/13728
The radiopaque marker bands 208 and 210 are visible on a
fluoroscope and aid in the placement of the device. When the
distal end portion of the elongated tube is positioned such that
the selected site is located between marker bands 208 and 210,
liquid may be pumped through the lumen 202 to move the treating
elements to the distal end portion of the elongated catheter
tube, where they are accounted for by the positioning of the
marker bands. After sufficient irradiation has occurred, the
flow through the device is reversed by reversing the flow of
pressurized fluid through the return lumen causing return of the
treating elements to the loading device. The elongated catheter
tube may then be removed from the patient and the procedure
completed.
A further alternative embodiment of the catheter of the
present invention, preferably intended for placement over a guide
wire, is shown in Figures 8A and 8B. The elongated catheter tube
212 comprises a pair of inner tubes 214 and 216 that extend in a
parallel side-by-side arrangement within an outer tube 218. As
in the Figure 7 embodiment, inner tube 214, which is of smaller
diameter than tube 216, defines an inner lumen 220 for receiving
a guide wire used for placement of the catheter at the desired
location within the patient. Inner tube 216, which is of larger
diameter, provides inner lumen 222 along which the treating
elements 22 travel. A return lumen 224 is provided by the space
between the inner surface of the outer tube 218 and the outer
surfaces of the inner tubes 214 and 216 for return flow of liquid
used to transport the treating elements, in the very same manner
as depicted in Figure 7B. In the Figure 8 embodiment, however,
inner tube 214 (for the guide wire) extends fully along the
length of the outer tube 218, and is bonded to the outer tube at
the distal-most location, where the outer tube is tapered.
In Figure 8A, an internal barrier 226 is provided at the end
of the inner tube 216, through which the treating elements are
carried, to block the passage of treating elements from the
distal end of the tube 216. A center opening in the barrier 226
allows liquid to pass from the lumen 222 of the inner tube 216 to
the return lumen. Alternatively, the barrier may be solid as
- 28 -


CA 02362617 2001-11-26
WO 96/13303 PC?/US95113728
3epicted with barrier 228 in Figure 8B (which is otherwise the
same as Figure 8A), and an aperture 230 may be provided in the
wall of inner tube 216 to permit liquid to flow between the
treating element lumen 222 and the return lumen. Although not
depicted in Figures 8A or 8B, it should be understood that the
elongated catheter tube may also include a series of marker bands
appropriately placed along the length of the tube to aid in
accurate placement in the patient.
Another embodiment of the catheter of the present invention
is shown in Figure 9. As shown there, catheter 232 has three co-
axial tubes, inner tube 234, outer tube 236 and intermediate tube
238, which all extend the full length of the catheter. Inner
tube 234 has a lumen 240 for receiving a guide wire for placement
of the catheter at the desired location in the patient. Inner
tube 234 is spaced from intermediate tube 238 to define an
annular treating element passageway 242 therebetween. In this
embodiment, the treating elements are preferably ring shaped, as
at 244, or donut shaped, as at 246, to allow them to slide over
the inner tube 234 and along the passageway 242. To provide a
return flow channel, the inner diameter of the outer tube 236 is
slightly larger than the intermediate tube 238 to provide a
return flow path 248 therebetween.
The end of the catheter is closed by a molded tip plug 250,
preferably of radiopaque material, bonded to the ends of the
inner and outer tubes 234 and 236. Center passageway 252 through
the tip plug allows for the passage of a guide wire or the like
for placement of the catheter at the desired location. The
distal end of the intermediate tube 238 stops short of the tip
plug, thereby allowing the treating element passageway 242 to
communicate directly with the return flow path 248. Radiopaque
marker bands, although not shown, may also be incorporated on the
distal end portion of the elongated catheter tube to aid in
placing the elongated tube within the body at the selected site.
After the distal end portion of the elongated tube is
positioned at the desired location in the patient, a liquid, such
as saline, is forced through the treating element passageway 242
and directed against the ring-shaped treating elements, roving
- 29 -


CA 02362617 2001-11-26
. WO 96113303 PCTlUS95I13718
the treating elements along the passageway over the inner tube
234 until they abut the distal tip plug 250. The radioactive
elements are retained at the distal end portion of the elongated
catheter tube for a sufficient time to deliver the
therapeutically effective amount of radiation to the selected
site. To retrieve the treating elements, the fluid flow is
reversed through the flow path by forcing liquid in a distal
direction through the return lumen. Following this the
elongated tube can be removed over the guide wire and the
l0 procedure completed.
In a still further embodiment of the present invention,
shown in Figure 10, a catheter 254 is provided which includes
both an inflatable balloon membrane 256 for carrying out a
balloon angioplasty procedure and treating elements 22 fixed in
the distal end of the catheter for simultaneous treatment. The
catheter of Figure 10 includes an elongated tubular portion 258,
typically of extruded construction, with a guide wire lumen 260
and an inflation lumen 262. A balloon membrane is located at the
distal end of the catheter tube and sealed to the exterior
surface to form an inflatable balloon. Port 264 communicates
between the inflation lumen and the inside of the balloon for
inflating the balloon by pressurized liquid. Only the distal end
portion of the catheter is shown -- the proximal end of the
catheter being typical of angioplasty catheter construction as is
well known to those skilled in the field
To perform radiation treatment simultaneously with a balloon
angioplasty procedure, radioactive treating elements 22 are
located within the balloon, between coaxial walls 266 and 268 of
the distal end portion of the catheter. The treating elements
are ring-shaped or donut-shaped, as described earlier, and
positioned over the inner wall 266. Stop rings 270, preferably
of radiopaque material, are positioned at each end of the string
of treatment elements to maintain the treatment elements at a
fixed location within the balloon and aid in locating the
catheter at the desired location.
The strength and other characteristics of the radioactive
treating elements are essentially as described earlier and will
- 30 -


CA 02362617 2001-11-26
~ WO 96/13303
PCT/US95/13~28
.iot be repeated. With this construction, the balloon angioplasty
procedure and the radiation treatment of the stenotic site may be
carried out simultaneously instead of sequentially, thereby
further reducing the time, cost and risk associated with such
procedures.
In use, catheter 254 is positioned into the stenosed area of
the artery over a pre-positioned guide wire. Using the
radioactive treating elements alone or in conjunction with the
radiopaque end rings, the distal end portion of the catheter is
l0 positioned such that the balloon portion is located at the
stenosed site. Pressurized fluid introduced into the proximal
end of the inflation lumen, as with a syringe, enters through
port 264, inflating the balloon. The expanding balloon membrane
256 compresses the sclerotic plaque and increases the diameter of
the blood vessel. The balloon may be deflated and the distal tip
retained in this position for the desired period of time to
deliver an effective amount of radiation to the previously
stenosed area. The device may then be removed from the patient
and the procedure completed.
Figure 11 shows a variation of the radiation delivery system
of Figure 10. In the Figure 11 embodiment, the basic operation
and construction of the catheter are the same as described with
respect to that shown in Figure 10, except that in Figure 11, the
radioactive treating elements are located on inner tube 272 and
directly below balloon membrane 274. Balloon membrane may be
inflated by the introduction of pressurized fluid through
inflation lumen 276 defined between inner tube 272 and co-axial
outer tube 278.
Figure 12 shows the distal end portion of another balloon
catheter 280 embodying the present invention. The catheter 280
employs three coaxial tubes, inner tube 282, outer tube 284 and
intermediate tube 286. Inner tube 282 defines an inner lumen 288
through which a guide wire may extend for placement of the
catheter at the desired location. The space between the inner
tube and the intermediate tube 286 defines an annular lumen 290,
through which ring-shaped or donut-shaped treating elements may
pass. The space between the intermediate tube and the outer tube
- 31 -


CA 02362617 2001-11-26
284 forms a return lumen 292 for return of liquid used to
transport the treating elements.
The catheter 280 also includes a balloon membrane 294
bonded at one end to the exterior surface of the outer tube 284
and bonded to the exterior surface of the inner tube 282 (which
extends beyond the distal ends of the intermediate and outer
tubes) at the other end. The distal end of the outer tube is
closed by a barrier 296, which may be radiopaque, to block the
exit of the treating elements from the distal end of lumen 290.
In this embodiment, the same liquid used to transport the
treating elements is also used to inflate the balloon membrane,
although that is not required if a separate inflation lumen were
provided. To inflate the balloon membrane, a side opening 298
or port is provided in the wall of the outer tube 284 and also
in the intermediate tube 286 if desired. With this
construction, pressurized blood-compatible liquid, such as
sterile saline, may be used to inflate the balloon while
simultaneously advancing the treating elements to the distal end
portion of the catheter. The treating elements may be retrieved
by reversing the flow of the liquid through the return and
treating element lumen 292 and 290, respectively. Further
release of pressure exerted upon the liquid will allow the
balloon to deflate and the catheter to be removed.
Figure 13 illustrates a still further embodiment of a
balloon catheter 300 which has a pair of adjacent parallel inner
tubes, 302 and 304, forming guide wire lumen 306 and a treating
element lumen 308. In a manner similar to Figures 7 and 8, the
inner tubes are contained within an outer tube and the interior
space therebetween forms a return lumen. A balloon membrane 310
is bonded to the outer surface of the outer tube, forming an
inflatable balloon. The balloon membrane nay be inflated,
through side port 312 in the wall of inner tube 304, by the sane
blood-compatible liquid that is used to propel the treating
elements along the lumen 308. As in Figure 12, this catheter
permits expansion of the balloon membrane to carry out an
angioplasty procedure within a blood vessel at the same time the
treating elements are being moved to the distal end portion of
- 32 -


CA 02362617 2001-11-26
WO 96/13303
PCT/US95/13728
the catheter (where the balloon is located) to effect radiation
treatment of the tissue being subjected to the balloon
angioplasty procedure.
Figure 14 shows a device that is essentially identical to
that shown in Figure 2C and described in detail earlier, except
that the body member 94 includes a latch 314, such as spring
loaded pin, to retain insert 110 within chamber of cavity 108. A
release mechanism 316 may also be provided to release the
insert.
Figures 15A-15C show another embodiment of treatment
delivery system that is similar in many respects to the
embodiment shown in Figure 2C. In this embodiment, however, the
gate 114 is in the form of a disc 318 pivotally mounted at the
distal end of the insert 110. The disc includes a pair of
spaced-apart apertures 320 and 322, of different sizes,
therethrough, which may be moved into alignment with the center
bore 112 of the insert. One of the apertures 320 is smaller in
diameter than the treating elements 22, and when aligned with the
bore 112 blocks the passage of treating elements from the bore
while allowing liquid to pass therethrough for priming and the
like. Alternatively, the disc may be pivoted to a position where
the larger aperture 322 is aligned with the center bore 112,
which allows the treating elements to be ejected from the insert
by liquid flow pressure and advanced into and through the
catheter. For shipment and storage, the disc may be positioned
to fully cover the bore 112 of the insert.
In this embodiment, the body 94 includes a pair of opposed
side access openings 324 for accessing the disc 318 to pivot it
between the desired positions, and a pair of opposed viewing
access openings 326 for visually verifying the location of the
treating elements. In this embodiment, the catheter 92 has a
proximal fitting 328 for attachment to the distal end of, the body
94. This fitting may be keyed to assure that it is attached in
the proper relationship to the body and the correct lumen of the
catheter are aligned with the proper passageways of the body.
Figure 16 shows a simplified version of the treating system
of the present invention. As shown there, the treating elements
- 33 -


CA 02362617 2001-11-26
. . WO 96/13303 PCT/US95/13728
~2 are contained in a central passageway 330 of a solid body
332. Female luer lock connector 334 is provided at the inlet end
of the passageway and male luer lock connector 336 is provided at
the outlet end of the passageway, although a keyed fitting as
described above also may be used.
During travel and storage a temporary female luer lock
connector 338 is attached to the outlet connector 336. The
connector 338 includes a pin 340 that extends from the connector
into the passageway to hold the treating elements in place and
provide a barrier against the escape of radiation. The inlet end
of the passageway is smaller than the treating elements, thereby
keeping the treating elements located in generally the center of
the body 332.
To use this embodiment, the temporary connector 338 is
removed and a female luer lock connector (or keyed connector, as
discussed above) connector 342 at the proximal end of single
lumen catheter 344 is attached to the outlet connector 336. A
source, such as a syringe or suspended container, of blood-
compatible liquid, such as saline, is attached to the inlet
connector 334, and liquid is allowed to flow through the center
passageway, ejecting the treating elements 22 and forcing them
along the length of the catheter from the proximal to the distal
end portion, which is presumable located at the site in the
vascular system where treatment is desired. After the treatment
is complete, the treating elements are removed by withdrawing the
catheter from the patient's body or by applying a suction to the
proximal end to return the treating elements by the force of
reversed liquid flow.
Figure 17 is identical to Figure 12, except that a fourth
co-axial outer tube 346 is provided over tube 284, and the end of
the balloon membrane 294 is bonded to the outer tube 346 instead
of the tube 284. The distal end of the outermost tube 346
terminates just inside the balloon membrane, and the space
between the outermost tube 346 and the tube 284 provides an
inflation lumen 348 through which pressurized fluid may flow
directly into the area beneath the membrane to inflate the
balloon. This construction allows a separate source of
- 34 -


CA 02362617 2001-11-26
R'O 96113303 PC?/US95/13~28
pressurized fluid to be used to inflate the balloon membrane, and
inflation of the balloon membrane is not dependent on the
pressure of the liquid used to move the treating elements to the
distal end portion of the catheter.
Similarly, Figure 18 is identical to Figure 13, except that
an additional tube 350 is provided over the other tubes described
in connection with Figure 13, and one end of the balloon membrane
310 is bonded to surface of the tube 350. As with Figure 17, the
space between the additional tube 350 and the tubes described
earlier provides an inflation lumen 352, the distal end of which
lumen opens directly in the area beneath the balloon membrane.
This construction also allows a source of fluid, independent of
the liquid used to move the treating elements, to be used to
inflate the membrane in carrying out an angioplasty procedure.
Figure 19 shows a still further embodiment of the distal end
portion of a catheter 354 having an elongated inner tube 356
(which extends from a proximal end portion, not shown) defining
an inner lumen 358. The inner tube 356 extends co-axially within
an outer tube 360, the distal end of which stops short of the
distal end of the inner tube. Balloon membrane 362 is attached
at one end to the surface of outer tube 360 and is attached at
the other end to the surface of the inner tube 356. The space
between the inner and outer tubes forms an inflation lumen 364,
through which liquid may be introduced to inflate the balloon.
A separate elongated catheter tube 364 is insertable into
inner lumen 358 such that the distal end portion of the separate
tube lies within the area of the balloon. The separate tube also
has a lumen 366 extending from the proximal end (not shown)
through which treating elements 22 are movable under the force of
flowing liquid from the proximal to the distal end portion of the
catheter (the liquid in this embodiment exits through the distal
end of the lumen 358). .
Although the present invention has been described in terms
of certain specific embodiments, it is understood that various
changes and modifications may be made without departing from the
present invention, and reference should be made to the appended
claims to determine the proper scope of this invention.
- 35 -

A single figure which represents the drawing illustrating the invention.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Admin Status

Title Date
Forecasted Issue Date 2006-05-16
(22) Filed 1995-10-23
(41) Open to Public Inspection 1996-05-09
Examination Requested 2001-11-26
(45) Issued 2006-05-16
Lapsed 2013-10-23

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Request for Examination $400.00 2001-11-26
Registration of Documents $50.00 2001-11-26
Filing $300.00 2001-11-26
Maintenance Fee - Application - New Act 2 1997-10-23 $100.00 2001-11-26
Maintenance Fee - Application - New Act 3 1998-10-23 $100.00 2001-11-26
Maintenance Fee - Application - New Act 4 1999-10-25 $100.00 2001-11-26
Maintenance Fee - Application - New Act 5 2000-10-23 $150.00 2001-11-26
Maintenance Fee - Application - New Act 6 2001-10-23 $150.00 2001-11-26
Maintenance Fee - Application - New Act 7 2002-10-23 $150.00 2002-07-05
Maintenance Fee - Application - New Act 8 2003-10-23 $150.00 2003-10-10
Maintenance Fee - Application - New Act 9 2004-10-25 $200.00 2004-10-22
Maintenance Fee - Application - New Act 10 2005-10-24 $250.00 2005-10-19
Final $300.00 2006-03-06
Registration of Documents $100.00 2006-03-31
Maintenance Fee - Patent - New Act 11 2006-10-23 $250.00 2006-10-23
Maintenance Fee - Patent - New Act 12 2007-10-23 $250.00 2007-08-24
Maintenance Fee - Patent - New Act 13 2008-10-23 $250.00 2008-09-30
Maintenance Fee - Patent - New Act 14 2009-10-23 $250.00 2009-10-20
Maintenance Fee - Patent - New Act 15 2010-10-25 $450.00 2010-10-25
Maintenance Fee - Patent - New Act 16 2011-10-24 $450.00 2011-10-19
Current owners on record shown in alphabetical order.
Current Owners on Record
BEST VASCULAR, INC.
Past owners on record shown in alphabetical order.
Past Owners on Record
CROCKER, IAN R.
HILLSTEAD, RICHARD A.
LARSEN, CHARLES E.
MELOUL, RAPHAEL F.
NOVOSTE CORPORATION
ROSEN, JONATHAN J.
WAKSMAN, RON
WELDON, THOMAS D.
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.

To view selected files, please enter reCAPTCHA code :




Filter Download Selected in PDF format (Zip Archive)
Document
Description
Date
(yyyy-mm-dd)
Number of pages Size of Image (KB)
Representative Drawing 2002-01-07 1 10
Description 2001-11-26 35 2,009
Abstract 2001-11-26 1 29
Claims 2001-11-26 2 63
Drawings 2001-11-26 13 431
Cover Page 2002-02-15 1 47
Claims 2004-04-05 4 129
Description 2005-02-21 35 2,010
Claims 2005-02-21 3 111
Representative Drawing 2006-04-21 1 10
Cover Page 2006-04-21 1 47
Correspondence 2009-11-19 2 48
Prosecution-Amendment 2004-09-02 2 69
Correspondence 2009-11-06 1 23
Correspondence 2001-12-06 1 43
Correspondence 2002-01-08 1 13
Prosecution-Amendment 2003-10-06 2 76
Prosecution-Amendment 2005-02-21 9 323
Prosecution-Amendment 2004-04-05 7 191
Correspondence 2006-01-12 2 15
Correspondence 2006-01-05 3 100
Correspondence 2006-03-06 1 32
Correspondence 2009-09-15 5 183
Correspondence 2009-10-13 1 13
Correspondence 2009-10-13 1 15
Correspondence 2009-12-04 1 19
Correspondence 2010-09-13 3 72
Correspondence 2010-09-27 1 14
Correspondence 2010-09-27 1 16